TNFSF11 and neoplasm: Interestingly, as expected from its major implication in osteoclastogenesis, RANKL blockage using the IK22-5 antibody significantly preserved bone from its tumor-induced destruction (Figure 3A,C) with the presence of a significant decrease in the BS/TV and BS/BV parameters (Figure 3C).